Bausch Health
BHC
#3765
Rank
A$4.05 B
Marketcap
$10.95
Share price
1.47%
Change (1 day)
-21.77%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.00

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.22. In 2022 the company made an earnings per share (EPS) of -$0.99 an increase over its 2021 EPS that were of -$4.23.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.00305.39%
2022-$0.99-76.64%
2021-$4.2368.45%
2020-$2.51-68.91%
2019-$8.07-57.11%
2018-$18.81-272.22%
2017$10.92-199.29%
2016-$11.00798.7%
2015-$1.22-128.31%
2014$4.32-204.62%
2013-$4.13602.7%
2012-$0.59-171.15%
2011$0.83-143.96%
2010-$1.88-206.57%
2009$1.76-11.2%
2008$1.992.46%
2007$1.94-7.58%
2006$2.10-14.29%
2005$2.4554%
2004$1.59-500%
2003-$0.40-141.67%
2002$0.95-4.76%
2001$1.00-175%
2000-$1.34-268%
1999$0.7914.94%
1998$0.6920.83%
1997$0.5753.83%
1996$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.59-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.43-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA